Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Conditions

Mullerian Mixed Tumor of Ovary 1

Interventions

ficlatuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Mullerian Mixed Tumor of Ovary × ficlatuzumab × Clear all
NCT02090127 2015-07-29

Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient

AVEO Pharmaceuticals, Inc.

No longer available

Mullerian Mixed Tumor of Ovary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡